|
1
|
Kelsey JL and Bernstein L: Epidemiology
and prevention of breast cancer. Annu Rev Public Health. 17:47–67.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Preston-Martin S, Pike MC, Ross RK, Jones
PA and Henderson BE: Increased cell division as a cause of human
cancer. Cancer Res. 50:7415–7421. 1990.PubMed/NCBI
|
|
3
|
Hall JM and McDonnell DW: Coregulators in
nuclear estrogen receptor action – from concept to therapeutic
targeting. Mol Interv. 5:343–357. 2005.
|
|
4
|
Silva CM and Shupnik MA: Integration of
steroid and growth factor pathways in breast cancer: focus on
signal transducers and activators of transcription and their
potential role in resistance. Mol Endocrinol. 21:1499–1512. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Malley B: Coregulators: From whence came
these ‘master genes’. Mol Endocrinol. 21:1009–1013. 2007.PubMed/NCBI
|
|
6
|
Shao W, Halachmi S and Brown M: ERAP140, a
conserved tissue-specific nuclear receptor coactivator. Mol Cell
Biol. 22:3358–3372. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paramanik V and Thakur MK: Interaction of
estrogen receptor associated protein (ERAP) 140 with ER beta
decreases but its expression increases in aging mouse cerebral
cortex. Cell Mol Neurobiol. 30:961–966. 2010. View Article : Google Scholar
|
|
8
|
Arai H, Ozaki T, Niizuma H, Nakamura Y,
Ohira M, Takano K, Matsumoto M and Nakagawara A: ERAP140/Nbla10993
is a novel favorable prognostic indicator for neuroblastoma induced
in response to retinoic acid. Oncol Rep. 19:1381–1388.
2008.PubMed/NCBI
|
|
9
|
Shkolnik K, Ben-Dor S, Galiani D, Hourvitz
A and Dekel N: Molecular characterization and bioinformatics
analysis of Ncoa7B, a novel ovulation-associated and reproduction
system-specific Ncoa7 isoform. Reproduction. 135:321–333. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Durand M, Kolpak A, Farrell T, Elliott NA,
Shao W, Brown M and Volkert MR: The OXR domain defines a conserved
family of eukaryotic oxidation resistance proteins. BMC Cell Biol.
8:132007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reding KW, Weiss NS, Chen C, Li CI,
Carlson CS, Wilkerson HW, Farin FM, Thummel KE, Daling JR and
Malone KE: Genetic polymorphisms in the catechol estrogen
metabolism pathway and breast cancer risk. Cancer Epidemiol
Biomarkers. 18:1461–1467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsieh SM, Smith RA, Lintell NA, Hunter KW
and Griffiths LR: Polymorphisms of the SIPA1 gene and sporadic
breast cancer susceptibility. BMC Cancer. 9:3312009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giess M, Lattrich C, Springwald A, Goerse
R, Ortmann O and Treeck O: GPR30 gene polymorphisms are associated
with progesterone receptor status and histopathological
characteristics of breast cancer patients. J Steroid Biochem Mol
Biol. 118:7–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kirchhoff T, Chen ZQ, Gold B, Pal P,
Gaudet MM, Kosarin K, Levine DA, Gregersen P, Spencer S, Harlan M,
Robson M, Klein RJ, Hudis CA, Norton L, Dean M and Offit K: The
6q22.33 locus and breast cancer susceptibility. Cancer Epidemiol
Biomarkers. 18:2468–2475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomas G, Jacobs KB, Kraft P, et al: A
multistage genome-wide association study in breast cancer
identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
Nat Genet. 41:579–584. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng W, Long J, Gao YT, et al:
Genome-wide association study identifies a new breast cancer
susceptibility locus at 6q25.1. Nat Genet. 41:324–328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garcia-Closas M and Chanock S: Genetic
susceptibility loci for breast cancer by estrogen receptor status.
Clin Cancer Res. 14:8000–8009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye S, Dhillon S, Ke X, Collins AR and Day
IN: An efficient procedure for genotyping single nucleotide
polymorphisms. Nucleic Acids Res. 29:E88–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lazennec G, Ediger TR, Petz LN, Nadulli AM
and Katzenellenbogen BS: Mechanistic aspects of estrogen receptor
activation probed with constitutively active estrogen receptors:
correlations with DNA and coregulator interactions and receptor
conformational changes. Molecular Endocrinology. 11:1375–1386.
1997. View Article : Google Scholar
|
|
20
|
Liu Y, Shi Y, Guo T, et al: No association
between the nuclear receptor coactivator 7 gene and schizophrenia
in the Chinese Han population. Schizophr Res. 89:360–361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
